Editorial Board
Antonio Ruggiero PhD
Agostino Gemelli University Polyclinic, Rome, Lazio · Italy
Editorial leadership for Journal of Advances in Leukemia
Research interests
- His Research Interests Focus On Pediatric Clinical Trials
- Clinical Pharmacology Of Antineoplastic Drugs
- Pain Therapy
- Pediatric Drugs
Biography
- Dr. Ruggiero received his medical degree from the Catholic University in Rome in 1992.
- He holds Board of Pediatrics in 1996 and Board of Pediatric Haematology and Oncology in 1998 at the Catholic University of Rome.
- Dr. Ruggiero is currently an aggregate professor in the Department of Pediatrics at the Catholic University of Rome where he is responsible for teaching Pediatrics and Pediatric Hematology and Oncology.
- Carrying a regular patient load as consultant in pediatric oncology allows him to maintain his clinical skills and to promote improvements in safety and quality of healthcare.
- Examples of activities include producing guidelines for prevention of healthcare associated treatments and improvements in basic safe medical practices.
Selected publications
- Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment 2021 cited 124×
- Renal toxicity and chemotherapy in children with cancer 2017 cited 75×
- Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers 2023 cited 62×
- Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment 2018 cited 59×
- Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients 2023 cited 58×
- Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors 2019 cited 56×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JAL for your work?
This journal is guided by Antonio Ruggiero (Agostino Gemelli University Polyclinic, Rome, Lazio) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.